Cellromax Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jun '26 Jun 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	49,132	73,574	57,231
Market Cap Growth	-12.90%	28.56%	-
Enterprise Value	40,252	68,367	-
Last Close Price	4450.00	6435.26	4704.43
PE Ratio	14.73	24.80	14.99
PS Ratio	2.34	3.32	2.65
PB Ratio	1.03	1.57	1.29
P/TBV Ratio	1.10	1.67	1.39
P/FCF Ratio	23.95	43.11	9.40
P/OCF Ratio	23.07	41.21	9.09
EV/Sales Ratio	1.92	3.08	-
EV/EBITDA Ratio	14.34	20.63	-
EV/EBIT Ratio	17.27	24.11	-
EV/FCF Ratio	19.62	40.06	-
Debt / Equity Ratio	0.01	0.01	0.03
Debt / EBITDA Ratio	0.14	0.14	0.25
Debt / FCF Ratio	0.19	0.28	0.25
Net Debt / Equity Ratio	-0.19	-0.15	-0.48
Net Debt / EBITDA Ratio	-3.16	-2.18	-3.58
Net Debt / FCF Ratio	-4.33	-4.23	-3.49
Asset Turnover	0.42	0.44	-
Inventory Turnover	2.28	2.14	-
Quick Ratio	3.21	3.08	7.41
Current Ratio	4.87	5.20	9.10
Return on Equity (ROE)	7.58%	6.49%	-
Return on Assets (ROA)	2.89%	3.54%	-
Return on Invested Capital (ROIC)	5.94%	7.74%	17.55%
Return on Capital Employed (ROCE)	4.80%	5.90%	12.00%
Earnings Yield	6.96%	4.03%	6.67%
FCF Yield	4.18%	2.32%	10.64%
Payout Ratio	99.15%	114.25%	-
Buyback Yield / Dilution	-5.97%	-9.70%	-